Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Amber Lord
Observed name:
Lord, Amber
Institution:
University of Plymouth
Observed institutions:
University Hospitals Plymouth NHS Trust,
University of Plymouth
OpenAlex ID:
A5086701838
An open-label, clinical feasibility study of the efficacy of Remdesivir for Long-COVID
2026
·
Helen Neilens
, Victoria Allgar
, et al.
·
Pilot and Feasibility Studies
·
4
Efficacy of peroneal nerve functional electrical stimulation (FES) for the reduction of bradykinesia in Parkinson’s disease: an assessor-blinded randomised controlled trial (STEPS II)—study protocol
2025
·
Abbey Tufft
, Helen Neilens
, et al.
·
BMJ Open
·
1
PDF
Whole body fluorine-18 fluorodeoxyglucose parametric PET/computed tomography in people with long coronavirus disease: the ERASE-LC trial protocol
2026
·
Hairil Rashmizal Abdul Razak
, W. David Strain
, et al.
·
Nuclear Medicine Communications
An open-label, clinical feasibility study of the efficacy of Remdesivir for Long-COVID
2026
·
Neilens, Helen
, Allgar, Victoria
, et al.
·
Figshare
An open-label feasibility study of remdesivir in long COVID: results from the ERASE LC trial
2026
·
Mark A Faghy
, Jade Chynoweth
, et al.
·
Oxford Open Immunology
367. Randomised Controlled Trial (feasibility Study) of Prophylactic Pyloric Balloon Dilatation During Ivor Lewis Esophagectomy to Prevent Delayed Gastric Emptying
2022
·
Mohamed Abdelrahman
, Helen Neilens
, et al.
·
Diseases of the Esophagus
Show more works
View as search
Works count:
8
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type